Can Measuring the Ankle-Brachial Index Improve Public Health?

Journal of the American College of Cardiology

Volumn 52, Issue 21, 2008, Pages 1743-1744

  Hiatt, William R ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

cardiovascular diseases; morbidity; mortality; peripheral vascular disease; risk factors

Indexed keywords

ANKLE BRACHIAL INDEX; ARTERY DISEASE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CLINICAL TRIAL; DISEASE SEVERITY; EDITORIAL; HUMAN; MORTALITY; PREVALENCE; PRIORITY JOURNAL;

ANKLE BRACHIAL INDEX; ARTERIAL OCCLUSIVE DISEASES; COMORBIDITY; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; PERIPHERAL VASCULAR DISEASES; PREDICTIVE VALUE OF TESTS; PUBLIC HEALTH; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS;

EID: 55649090797     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.08.035     Document Type: Editorial

References (18)

1. Selvin E., and Erlinger T.P. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 110 (2004) 738-743
2. Hirsch A.T., Criqui M.H., Treat-Jacobson D., et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 286 (2001) 1317-1324
3. Brass E.P., and Hiatt W.R. Review of mortality and cardiovascular event rates in patients enrolled in clinical trials for claudication therapies. Vasc Med 11 (2006) 141-145
4. Brass E.P., Anthony R., Dormandy J., et al. Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia. J Vasc Surg 43 (2006) 752-759
5. Steg P.G., Bhatt D.L., Wilson P.W., et al. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 297 (2007) 1197-1206
6. McDermott M.M., Tian L., Liu K., et al. Prognostic value of functional performance for mortality in patients with peripheral artery disease. J Am Coll Cardiol 51 (2008) 1482-1489
7. Beckman J.A., Preis O., Ridker P.M., and Gerhard-Herman M. Comparison of usefulness of inflammatory markers in patients with versus without peripheral arterial disease in predicting adverse cardiovascular outcomes (myocardial infarction, stroke, and death). Am J Cardiol 96 (2005) 1374-1378
8. Mohler III E.R., Treat-Jacobson D., Reilly M.P., et al. Utility and barriers to performance of the ankle-brachial index in primary care practice. Vasc Med 9 (2004) 253-260
9. O'Hare A.M., Katz R., Shlipak M.G., Cushman M., and Newman A.B. Mortality and cardiovascular risk across the ankle-arm index spectrum: results from the Cardiovascular Health Study. Circulation 113 (2006) 388-393
10. Fowkes F.G., Murray G.D., Butcher I., et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA 300 (2008) 197-208
11. Criqui N.H., Ninomiya J.K., Wingard D.L., Ming J., and Fronek A. Progression of peripheral arterial disease predicts cardiovascular disease morbidity and mortality. J Am Coll Cardiol 52 (2008) 1736-1742
12. Feringa H.H., Karagiannis S.E., Schouten O., et al. Prognostic significance of declining ankle-brachial index values in patients with suspected or known peripheral arterial disease. Eur J Vasc Endovasc Surg 34 (2007) 206-213
13. Hirsch A.T., Murphy T.P., Lovell M.B., et al. Gaps in public knowledge of peripheral arterial disease: the first national PAD public awareness survey. Circulation 116 (2007) 2086-2094
14. Selvin E., and Hirsch A.T. Contemporary risk factor control and walking dysfunction in individuals with peripheral arterial disease: NHANES 1999-2004. Atherosclerosis (2008) In press
15. Hirsch A.T., Haskal Z.J., Hertzer N.R., et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary: a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease). J Am Coll Cardiol 47 (2006) 1239-1312
16. Norgren L., Hiatt W.R., Dormandy J.A., Nehler M.R., Harris K.A., and Fowkes F.G. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 45 (2007) S5-S67
17. U.S. Preventive Services Task Force. Screening for Peripheral Arterial Disease: Recommendation Statement. AHRQ Publication No.05-0583-A-EF (August 2005), Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/clinic/uspstf05/pad/padrs.htm Accessed September 11, 2008
18. Hirsch A.T., Hartman L., Town R.J., and Virnig B.A. National health care costs of peripheral arterial disease in the Medicare population. Vasc Med 13 (2008) 209-215